Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1998-11-9
pubmed:abstractText
The activities of a panel of currently available antibiotics and the investigational agents LY 333328, linezolid, CL 331,002, CL 329,998, moxifloxacin (BAY 12-8039), trovafloxacin, and quinupristin-dalfopristin against 274 clinical isolates of enterococci were determined. No vancomycin resistance or beta-lactamase production was observed. Except for 12 isolates (all non-Enterococcus faecalis) showing reduced susceptibility to quinupristin-dalfopristin (MIC, >/=4 microg/ml), the new agents exhibited promising in vitro antienterococcal activity.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756791-1963528, http://linkedlifedata.com/resource/pubmed/commentcorrection/9756791-2404568, http://linkedlifedata.com/resource/pubmed/commentcorrection/9756791-2656745, http://linkedlifedata.com/resource/pubmed/commentcorrection/9756791-3125217, http://linkedlifedata.com/resource/pubmed/commentcorrection/9756791-7623654, http://linkedlifedata.com/resource/pubmed/commentcorrection/9756791-7628198, http://linkedlifedata.com/resource/pubmed/commentcorrection/9756791-7811025, http://linkedlifedata.com/resource/pubmed/commentcorrection/9756791-7852554, http://linkedlifedata.com/resource/pubmed/commentcorrection/9756791-8285606, http://linkedlifedata.com/resource/pubmed/commentcorrection/9756791-8851600, http://linkedlifedata.com/resource/pubmed/commentcorrection/9756791-8878606, http://linkedlifedata.com/resource/pubmed/commentcorrection/9756791-8957575
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2752-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
In vitro activities of 15 antimicrobial agents against clinical isolates of South African enterococci.
pubmed:affiliation
Department of Medical Microbiology, University of the Orange Free State, Bloemfontein 9300, South Africa. GNMBDS@med.uovs.ac.za
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't